Ollin Biosciences

📍 Austin, United States👥 19 employees💰 Last funded Feb 2024
Biotechnology Research🌐 ollin.bio
Website LinkedIn
Ollin Biosciences is a clinical-stage biopharmaceutical company dedicated to acquiring and developing best-in-disease therapies for vision-threatening diseases. With a differentiated pipeline, world-class team, and strong investor syndicate, Ollin is redefining what’s possible in ophthalmology.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United Kingdom
1
United States
1
Frequently asked questions
Who invested in Ollin Biosciences?
Ollin Biosciences has 2 investors on record on gritt.io.
When did Ollin Biosciences last raise funding?
The most recent investment in Ollin Biosciences recorded on gritt.io was in February 2024.
What industry is Ollin Biosciences in?
Ollin Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Ollin Biosciences based?
Ollin Biosciences is headquartered in Austin, United States.